Literature DB >> 15212876

Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions.

D J van Drooge1, W L J Hinrichs, H W Frijlink.   

Abstract

In this study, anomalous dissolution behaviour of tablets consisting of sugar glass dispersions was investigated. The poorly aqueous soluble diazepam was used as a lipophilic model drug. The release of diazepam and sugar carrier was determined to study the mechanisms governing dissolution behaviour. The effect of carrier dissolution rate and drug load was tested with four different sugars, in the order of decreasing dissolution rates: sucrose, trehalose and two oligo-fructoses; inulinDP11 and inulinDP23 having a number average degree of polymerization (DP) of 11 and 23, respectively. Diazepam was incorporated in these sugar glasses in the amorphous state by means of freeze drying using water and tertiary butyl alcohol (TBA) as solvents. None of the tablets disintegrated during dissolution. Dissolution of 80% of the lipophilic drug within 20 min was found when diazepam and sugar dissolution profiles coincided. The sugar carrier and diazepam dissolved at the same rate, which was constant in time and fast. This condition was met for relatively slow dissolving carriers like the inulins or for low drug loads. For relatively fast dissolving carriers like sucrose or trehalose with high drug loads, release profiles of diazepam and sugar did not coincide: diazepam dissolved much more slowly than the sugars. In case of non-coinciding release profiles, diazepam release was split into three phases. During the first phase non-steady-state dissolution was observed: diazepam release accelerated and a drug rich layer consisting of crystalline diazepam was gradually formed. This first phase determined the further release of diazepam. During the second phase a steady-state release rate was reached: zero-order release was observed for both drug and carrier. During this phase, the remaining (non-crystallised) solid dispersion is dissolved without the further occurrence of crystallisation. The third phase, starting when all carrier is dissolved, involved the very slow dissolution of crystallised diazepam, which was present either as the skeleton of a tablet resulting in a zero-order release profile or as separate particles dispersed in the dissolution medium resulting in a first-order release. To understand the anomalous dissolution behaviour, a model is proposed. It describes the phenomena during dissolution of amorphous solid dispersion tablets and explains that fast dissolution is observed for low drug loads or slow dissolving carriers like inulin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212876     DOI: 10.1016/j.jconrel.2004.03.018

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

Review 1.  Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Arpit Bhargava; Dinesh Kumar Jain; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

2.  Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.

Authors:  Anjali Agrawal; Mayur Dudhedia; Weibin Deng; Kevin Shepard; Li Zhong; Edward Povilaitis; Ewa Zimny
Journal:  AAPS PharmSciTech       Date:  2016-01-12       Impact factor: 3.246

3.  Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.

Authors:  Hemlata Patil; Xin Feng; Xingyou Ye; Soumyajit Majumdar; Michael A Repka
Journal:  AAPS J       Date:  2014-10-25       Impact factor: 4.009

4.  Characterization of a cyclosporine solid dispersion for inhalation.

Authors:  Gerrit S Zijlstra; Michiel Rijkeboer; Dirk Jan van Drooge; Marc Sutter; Wim Jiskoot; Marco van de Weert; Wouter L J Hinrichs; Henderik W Frijlink
Journal:  AAPS J       Date:  2007-06-15       Impact factor: 4.009

5.  Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods.

Authors:  Alireza Homayouni; Fatemeh Sadeghi; Ali Nokhodchi; Jaleh Varshosaz; Hadi Afrasiabi Garekani
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

6.  Dissolution and uniformity of content of tablets developed with extract of Ximenia americana L.

Authors:  Cleildo P Santana; Francinalva D Medeiros; Lidiane P Correia; Paulo Henrique G D Diniz; Germano Véras; Ana Cláudia D Medeiros
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

7.  Stabilisation and Growth of Metastable Form II of Fluconazole in Amorphous Solid Dispersions.

Authors:  Maciej Nowak; Maciej Gajda; Przemysław Baranowski; Patrycja Szymczyk; Bożena Karolewicz; Karol P Nartowski
Journal:  Pharmaceutics       Date:  2019-12-20       Impact factor: 6.321

Review 8.  Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs.

Authors:  Serena Bertoni; Beatrice Albertini; Nadia Passerini
Journal:  Molecules       Date:  2019-09-25       Impact factor: 4.411

9.  Improvement in solubility of poor water-soluble drugs by solid dispersion.

Authors:  Swati Sareen; George Mathew; Lincy Joseph
Journal:  Int J Pharm Investig       Date:  2012-01

10.  Development of micro-fibrous solid dispersions of poorly water-soluble drugs in sucrose using temperature-controlled centrifugal spinning.

Authors:  Stefania Marano; Susan Anne Barker; Bahijja Tolulope Raimi-Abraham; Shahrzad Missaghi; Ali Rajabi-Siahboomi; Duncan Q M Craig
Journal:  Eur J Pharm Biopharm       Date:  2016-03-21       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.